<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36280020</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Travel medicine and infectious disease</Title><ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Respiratory virus detection in returning travelers and pilgrims from the Middle East.</ArticleTitle><Pagination><StartPage>102482</StartPage><MedlinePgn>102482</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2022.102482</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1477-8939(22)00228-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pilgrims travelling to Saudi Arabia are commonly infected with respiratory viruses. Since the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) emerged in 2012, patients with acute respiratory symptoms returning from an endemic area can be suspected to be infected by this virus.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">98 patients suspected to have MERS-CoV infection from 2014 to 2019 were included in this retrospective cohort study. Upper and lower respiratory tract samples were tested by real-time RT-PCR for the detection of MERS-CoV and other respiratory viruses. Routine microbiological analyses were also performed. Patient data were retrieved from laboratory and hospital databases retrospectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All patients with suspected MERS-CoV infection travelled before their hospitalization. Most frequent symptoms were cough (94.4%) and fever (69.4%). 98 specimens were tested for MERS-CoV RNA and none of them was positive. Most frequently detected viruses were Enterovirus/Rhinovirus (40/83; 48.2%), Influenzavirus A (34/90; 37.8%) and B (11/90; 12.2%), H-CoV (229E and OC43 10/83; 12% and 7/83; 8.4%, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">From 2014 to 2019, none of 98 patients returning from endemic areas was MERS-CoV infected. However, infections with other respiratory viruses were frequent, especially with Enterovirus/Rhinoviruses and Influenzaviruses.</AbstractText><CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mercier</LastName><ForeName>Ambroise</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: ambroise.mercier.etu@univ-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Méheut</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Lille, Service des Maladies Infectieuses et Tropicales, Lille, France, F-59037, Lille, France. Electronic address: antoine.meheut.etu@univ-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alidjinou</LastName><ForeName>Enagnon Kazali</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: enagnonkazali.alidjinou@chru-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazrek</LastName><ForeName>Mouna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: mouna.lazrek@chru-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faure</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CHU Lille, Service des Maladies Infectieuses et Tropicales, Lille, France, F-59037, Lille, France; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France; Service de Maladies Infectieuses, CHU Lille, F-59000, Lille, France. Electronic address: karine.faure@chru-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hober</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: didier.hober@chru-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelmann</LastName><ForeName>Ilka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: ilka.engelmann@chu-montpellier.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Travel Med Infect Dis</MedlineTA><NlmUniqueID>101230758</NlmUniqueID><ISSNLinking>1477-8939</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="Y">Middle East Respiratory Syndrome Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008877" MajorTopicYN="N" Type="Geographic">Middle East</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Influenzavirus</Keyword><Keyword MajorTopicYN="N">Middle East respiratory syndrome coronavirus (MERS-CoV)</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">Pilgrims</Keyword><Keyword MajorTopicYN="N">Respiratory virus</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Saudi Arabia</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>24</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36280020</ArticleId><ArticleId IdType="pmc">PMC9584832</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2022.102482</ArticleId><ArticleId IdType="pii">S1477-8939(22)00228-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fehr A.R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol Clifton NJ. 2015;1282:1–23. doi: 10.1007/978-1-4939-2438-7_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2438-7_1</ArticleId><ArticleId IdType="pmc">PMC4369385</ArticleId><ArticleId IdType="pubmed">25720466</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016 Jun;24(6):4908. doi: 10.1016/j.tim.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.03.003</ArticleId><ArticleId IdType="pmc">PMC7125511</ArticleId><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin D.A., Gulick R.M., Martinez F.J. Severe Covid-19. Solomon CG, editor. N Engl J Med. 2020 Dec 17;383(25):2451. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov 8;367(19):1814–1820. doi: 10.1056/NEJMoa1211721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Middle East respiratory syndrome coronavirus (MERS-CoV) https://www.who.int/emergencies/disease-outbreak-news/item/2021-DON317</Citation></Reference><Reference><Citation>Bleibtreu A., Bertine M., Bertin C., Houhou-Fidouh N., Visseaux B. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV) Med Maladies Infect. 2020 May;50(3):243–251. doi: 10.1016/j.medmal.2019.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmal.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC7125975</ArticleId><ArticleId IdType="pubmed">31727466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S.Y., Kang J.M., Ha Y.E., Park G.E., Lee J.Y., Ko J.H., et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet Lond Engl. 2016;388(10048):994JY. doi: 10.1016/S0140-6736(16)30623-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30623-7</ArticleId><ArticleId IdType="pmc">PMC7159268</ArticleId><ArticleId IdType="pubmed">27402381</ArticleId></ArticleIdList></Reference><Reference><Citation>Prise en charge des patients suspects d’infections dues au nouveau coronavirus (HCoV-EMC) – 19 mars 2013. https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=314</Citation></Reference><Reference><Citation>Définition et classement des cas possibles et confirmés d’infection à MERS-CoV et précautions à mettre en œuvre lors de la prise en charge de ces patients - 24 avril 2015. https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=506</Citation></Reference><Reference><Citation>Mise en place d’une déclaration obligatoire des infections à MERS-CoV - 18 mai 2018. https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=669</Citation></Reference><Reference><Citation>Corman V.M., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 6;17(49) doi: 10.2807/ese.17.49.20334-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.17.49.20334-en</ArticleId><ArticleId IdType="pubmed">23231891</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman V.M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012 Sep 27;17(39) doi: 10.2807/ese.17.39.20285-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.17.39.20285-en</ArticleId><ArticleId IdType="pubmed">23041020</ArticleId></ArticleIdList></Reference><Reference><Citation>Guery B., Poissy J., el Mansouf L., Séjourné C., Ettahar N., Lemaire X., Vuotto F., Goffard A., Behillil S., Enouf V., Caro V., Mailles A., Che D., Manuguerra J.C., Mathieu D., Fontanet A., van der Werf S., MERS-CoV study group Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29;381(9885):2265–2272. doi: 10.1016/S0140-6736(13)60982-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60982-4</ArticleId><ArticleId IdType="pmc">PMC7159298</ArticleId><ArticleId IdType="pubmed">23727167</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkhy H.H., Memish Z.A., Bafaqeer S., Almuneef M.A. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Trav Med. 2006 Mar 10;11(2):82–86. doi: 10.2310/7060.2004.17027.</Citation><ArticleIdList><ArticleId IdType="doi">10.2310/7060.2004.17027</ArticleId><ArticleId IdType="pubmed">15109471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashem A.M., Al-Subhi A.M., Badroon T.L., Hassan N.A., Bajrai L.H.M., Banassir T.M., Alquthami K.M., Azhar E.I. MERS-CoV, influenza and other respiratory viruses among symptomatic pilgrims during 2014 Hajj season. J Med Virol. 2019 Jun;91(6):911–917. doi: 10.1002/jmv.25424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25424</ArticleId><ArticleId IdType="pmc">PMC7166944</ArticleId><ArticleId IdType="pubmed">30729547</ArticleId></ArticleIdList></Reference><Reference><Citation>Atabani S.F., Wilson S., Overton-Lewis C., Workman J., Kidd I.M., Petersen E., Zumla A., Smit E., Osman H. Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015. Int J Infect Dis. 2016 Jun;47:10–14. doi: 10.1016/j.ijid.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.04.016</ArticleId><ArticleId IdType="pmc">PMC7110479</ArticleId><ArticleId IdType="pubmed">27117200</ArticleId></ArticleIdList></Reference><Reference><Citation>Annan A., Owusu M., Marfo K.S., Larbi R., Sarpong F.N., Adudd I.M., et al. High prevalence of common respiratory viruses and no evidence of Middle East Respiratory Syndrome Coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health. 2015 Jun;20(6):807–812. doi: 10.1111/tmi.12482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.12482</ArticleId><ArticleId IdType="pmc">PMC7169725</ArticleId><ArticleId IdType="pubmed">25688471</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkouiten S., Charrel R., Belhouchat K., Drali T., Nougairede A., Salez N., et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov;20(11):1821–1827. doi: 10.3201/eid2011.140600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2011.140600</ArticleId><ArticleId IdType="pmc">PMC4214309</ArticleId><ArticleId IdType="pubmed">25341199</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubelt B., Lipton H.L. Handbook of clinical neurology. Elsevier; 2014. Enterovirus/Picornavirus infections; pp. 379–416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-53488-0.00018-3</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Treanor J.J., Hayden F.G., Vrooman P.S., Barbarash R., Bettis R., Riff D., et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000 Feb 23;283(8):1016. doi: 10.1001/jama.283.8.1016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.8.1016</ArticleId><ArticleId IdType="pubmed">10697061</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K., Aoki F., Osterhaus A., Trottier S., Carewicz O., Mercier C., Rode A., Kinnersley N., Ward P. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000 May 27;355(9218):1845–1850. doi: 10.1016/s0140-6736(00)02288-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(00)02288-1</ArticleId><ArticleId IdType="pubmed">10866439</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkouiten S., Al-Tawfiq J.A., Memish Z.A., Albarrak A., Gautret P. Clinical respiratory infection and pneumonia during the Hajj pilgrimage: a systematic review. Trav Med Infect Dis. 2019 Mar - Apr;28:15–26. doi: 10.1016/j.tmaid.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2018.12.002</ArticleId><ArticleId IdType="pmc">PMC7110718</ArticleId><ArticleId IdType="pubmed">30528743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim S.H., Memish Z.A. COVID-19 - the role of mass gatherings. Trav Med Infect Dis. 2020 Mar-Apr;34 doi: 10.1016/j.tmaid.2020.101617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101617</ArticleId><ArticleId IdType="pmc">PMC7102534</ArticleId><ArticleId IdType="pubmed">32165283</ArticleId></ArticleIdList></Reference><Reference><Citation>Thu T.P.B., Ngoc P.N.H., Hai N.M., Tuan L.A. Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries. Sci Total Environ. 2020 Nov 10;742 doi: 10.1016/j.scitotenv.2020.140430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.140430</ArticleId><ArticleId IdType="pmc">PMC7307990</ArticleId><ArticleId IdType="pubmed">32623158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashim H.T., Babar M.S., Essar M.Y., Ramadhan M.A., Ahmad S. The Hajj and COVID-19: how the pandemic shaped the world's largest religious gathering. Am J Trop Med Hyg. 2021 Jan 11;104(3):797–799. doi: 10.4269/ajtmh.20-1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-1563</ArticleId><ArticleId IdType="pmc">PMC7941851</ArticleId><ArticleId IdType="pubmed">33432907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>